DGX Stock Chart & Fundamental Analysis

Interactive Chart

About QUEST DIAGNOSTICS INC

Name

QUEST DIAGNOSTICS INC

CEO

James E. Davis

Website

www.questdiagnostics.com

Industry

Healthcare

Year Founded

1967

Employees

51,500

Quest Diagnostics Incorporated (NYSE: DGX) provides diagnostic information services, risk assessment services, and healthcare information technology in the medical diagnostics and research business. The company generated $11.0 billion of revenue in FY2025. Its work spans routine and advanced clinical testing, anatomic pathology, insurance-focused assessments, and software used by healthcare organizations and clinicians.

Analyst Ratings

Consensus Recommendation

Buy5

Hold2

Sell1

Fundamentals & Financials

Revenue (TTM)

$11.5B

Net Income (TTM)

$1B

EPS (TTM)

$9.54

ROA (TTM)

6.27%

Current Ratio

1.59

Dividend Yield

0.41%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Item	Q2 FY2026	Q1 FY2026	Q4 FY2025
Revenue	$3,043M	$2,895M	$2,806M
Cost of Sales	$2,016M	$1,953M	$1,892M
Gross Profit	$1,027M	$942,000K	$914,000K
Operating Income	$459,000K	$399,000K	$391,000K
Net Income	$320,000K	$252,000K	$245,000K
EPS	$2.88	$2.27	$2.21

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings Calendar

Technical Indicators

QUEST DIAGNOSTICS INC's Technical Indicators Summary

DGX presents a strong bullish regime where price is above short- and long-term averages and trend strength is robust. ADX shows a pronounced trend, and momentum signals such as CCI and MACD are supportive even as RSI appears elevated; volatility is moderate at roughly a two-percent ATR. The classic pivot is beneath the market, offering near-term support, while OBV is lagging and represents a notable divergence versus price strength. Technical takeaway: Strong Buy — a well-defined uptrend with broad moving-average support despite muted volume readings.

Buy

5 signals

Neutral

2 signals

Sell

1 signal

Overall: Bullish63% Bullish signals

Indicator	Value	Signal	Explanation
RSI (14)	71.15	Sell	RSI (71.15) > 70, indicating overbought conditions.
Stochastic %K (14, 3, 3)	70.12	Neutral	Stochastic (70.12) is neutral.
CCI (20)	125.27	—	CCI (125.27) > 100, indicating strong upward momentum.
WPR (14)	-14.76	—	Williams %R (-14.76) > -20, indicating overbought.
Momentum (10)	4.20	—	Momentum (4.20) is positive.
MFI	62.22	—	MFI (62.22) is neutral.
MACD Level (12, 26)	6.02	Neutral	Potential bearish reversal: MACD (6.02) crossed below signal but is still positive.
Bollinger Bands	$228.47 - $241.49	—	Price is within the bands.
ATR (14)	$5.17 (2.15%)	—	Moderate Volatility (2.15%).
ADX (14)	36.38	—	Strong uptrend (ADX > 25) with bullish directional movement. ADX(36.38), +DI(30.92), -DI(14.37)
OBV	-2,297,816	—	Bearish volume pressure: OBV is below its 20-day SMA. OBV(-2,297,816), 20D-SMA-OBV(-2,029,234)
Classic Pivot Point	$237.23	—	Price ($240.04) has broken above resistance R1 ($238.40) — bullish breakout potential.
Fibonacci Pivot Point	$237.23	—	Price ($240.04) has broken above resistance R1 ($238.50) — bullish breakout potential.
Exponential Moving Averages	$200.93 - $236.21(5 indicators)	Buy	EMA group: 5/5 bullish, 0 bearish, 0 neutral. Price above key EMA averages.
Simple Moving Averages	$197.51 - $237.20(5 indicators)	—	SMA group: 5/5 bullish, 0 bearish, 0 neutral. Price above key SMA averages.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

DGX managed a small uptick in the last trading session, closing at 236.25, up 0.31% from 235.52. M.D. Sass LLC buys new shares in DGX, signaling fresh investor interest in Quest Diagnostics.

Trading Volume

Below 10d avg (668.0K)

476.2K

vs S&P 500 Today

Outperforming Market

+1.00%

52-Week Position

Near highs

94.4%

Updated: August 19, 2026 at 12:45 UTC